Clinical Trial Update: Endostar Durative Transfusion Combining With Gemcitabine-Cisplatin to Treat Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Endostar with gemcitabine and cisplatin for non-small cell lung cancer is reported as a status update with unknown results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Endostar (recombinant human endostatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Beijing Chest Hospital | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN